In vitro activity of oxazaphosphorines in childhood acute leukemia: Preliminary report

Acta Biochimica Polonica

Volumn 49, Issue 1, 2002, Pages 221-225

  Styczyński, Jan ^a,i   Wysocki, Mariusz ^a   Dȩbski, Robert ^a   Balwierz, Walentyna ^b   Rokicka Milewska, Roma ^c   Matysiak, Michał ^c   Balcerska, Anna ^d   Kowalczyk, Jerzy ^e   Wachowiak, Jacek ^f   Sońta Jakimczyk, Danuta ^g   Chybicka, Alicja ^h  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^b JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^c MEDICAL UNIVERSITY OF WARSAW   (Poland)

^d MEDICAL UNIVERSITY OF GDANSK   (Poland)

^e MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^f POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^g MEDICAL UNIVERSITY OF SILESIA   (Poland)

^h WROCLAW MEDICAL UNIVERSITY   (Poland)

ⁱ NONE   (Poland)

Author keywords

ALL; Glufosfamide; Leukemia; Resistance; Sensitivity

Indexed keywords

4 HYDROPEROXYCYCLOPHOSPHAMIDE; 4-HYDROXYPEROXYCYCLOPHOSPHAMIDE; CYCLOPHOSPHAMIDE; DRUG DERIVATIVE; GLUCOSYL IFOSFAMIDE MUSTARD; GLUCOSYL-IFOSFAMIDE MUSTARD; MAFOSFAMIDE; PHOSPHORAMIDE MUSTARD;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADOLESCENT; ARTICLE; CELL CULTURE; CHILD; DRUG EFFECT; FEMALE; HUMAN; IN VITRO STUDY; INFANT; MALE; PRESCHOOL CHILD;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CYCLOPHOSPHAMIDE; FEMALE; HUMANS; INFANT; LEUKEMIA, LYMPHOCYTIC, ACUTE; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; PHOSPHORAMIDE MUSTARDS; TUMOR CELLS, CULTURED;

EID: 0036047152     PISSN: 0001527X     EISSN: None     Source Type: Journal    
DOI: 10.18388/abp.2002_3839     Document Type: Article

References (9)

1. Brock, N., Hilgard, P., Peukert, M., Pohl, J. & Sindermann, H. (1988) Basis and new developments in the field of oxazaphosphorines. Cancer Invest. 6, 513-532.
2. Hilgard, P. & Pohl, J. (1986) Short communication: Cause and prevention of mafosfamide-induced venous pain. Invest. New Drugs 4, 373-376.
3. Niemeyer, U., Engel, J., Hilgard, P., Peukert, M., Pohl, J. & Sindermann, H. (1989) Mafosfamide - a derivative of 4-hydroxycyclophosphamide. Prog. Clin. Biochem. Med. 9, 35-60.
4. Pohl, J., Bertram, B., Hilgard, P., Nowrousian, M.R., Stuben, J. & Wiessler, M. (1995) D-19575 - a sugar-linked isophosphoramide mustard derivative exploiting transmembrane glucose transport. Cancer Chemother. Pharmacol. 35, 364-370.
5. Stuben, J., Port, R., Bertram, B., Bollow, U., Hull, W.E., Schaper, M., Pohl, J. & Wiessler, M. (1996) Pharmacokinetics and whole-body distribution of the new chemotherapeutic agent beta-D-glucosylisophosphoramide mustard and its effects on the incorporation of [methyl-3-H]-thymidine in various tissues of the rat. Cancer Chemother. Pharmacol. 38, 355-365.
6. Veyhl, M., Wagner, K., Volk, C., Gorboulev, V., Baumgarten, K., Weber, W.M., Schaper, M., Bertram, B., Wiessler, M. & Koepsell, H. (1998) Transport of the new chemotherapeutic agent beta-D-glucosylisophosphoramide mustard (D-19575) into tumor cells is mediated by the Na+-D-glucose cotransporter SAAT1. Proc. Natl. Acad. Sci. U.S.A. 95, 2914-2919.
7. Seker, H., Bertram, B., Burkle, A., Kaina, B., Pohl, J., Koepsell, H. & Wiesser, M. (2000) Mechanistic aspects of the cytotoxic activity of glufosfamide, a new tumour therapeutic agent. Br. J. Cancer 82, 629-634.
8. Styczyński, J., Pieters, R., Huismans, D.R., Schuurhuis, G.J., Wysocki, M. & Veerman, A.J.P. (2000) In vitro drug resistance profiles in adult versus childhood acute lymphoblastic leukemia. Br. J. Haematol. 110, 813-818.
9. Makrynikola, V., Kabral, A. & Bradstock, K.F. (1991) Effect of mafosfamide (ASTA-Z-7654) on the clonogenic cells in precursor-B acute lymphoblastic leukaemia: Significance for ex vivo purging of bone marrow for autologous transplantation. Bone Marrow Transplant. 8, 351-355.